NSE BSE
mangalam drug & chem ltd stock

MANGALAM DRUG & CHEM LTD Share Price

- - (%)
Sector: -

11817

532637

MANGALAM

img img img img
No Data Available

MANGALAM DRUG & CHEM LTD Share Price Update


As of the latest trading session, MANGALAM DRUG & CHEM LTD share price is currently at 100.2, which is up by 0.39 from its previous closing. Today, the stock has fluctuated between 98.00 and 104.50. Over the past year, MANGALAM DRUG & CHEM LTD has achieved a return of -9.64 %. In the last month alone, the return has been 0.65 %.

MANGALAM DRUG & CHEM LTD Performance

Day Range

Low98.00 High104.50
101.30

52 Week Range

Low 90.80 High 132.45
101.30

Open Price

100.00

Prev. Close

99.80

Volume (Shares)

9783.00

Total traded value

9.91

Upper Circuit

104.75

Lower Circuit

94.85

Note: The current prices & values are delayed, Login to your account for live updates.

MANGALAM DRUG & CHEM LTD Fundamentals


(Standalone)

Market Cap (Cr) 160.30
PE Ratio (TTM) 0.00
Book Value / Share 87.76
Beta 0.69
ROE 0.84%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.50

MANGALAM DRUG & CHEM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 97.05
Operating Expense 97.29
Net Profit 0.50
Net Profit Margin (%) 0.51
Earnings Per Share (EPS) 0.32
EBITDA 6.97
Effective Tax Rate (%) -1150.00
Particulars SEP 2023 (Values in Cr)
Revenue 81.37
Operating Expense 86.33
Net Profit -3.56
Net Profit Margin (%) -4.37
Earnings Per Share (EPS) -2.25
EBITDA 2.22
Effective Tax Rate (%) 25.05
Particulars JUN 2023 (Values in Cr)
Revenue 87.00
Operating Expense 97.77
Net Profit -9.54
Net Profit Margin (%) -10.96
Earnings Per Share (EPS) -6.02
EBITDA -3.45
Effective Tax Rate (%) 7.28
Particulars MAR 2023 (Values in Cr)
Revenue 90.27
Operating Expense 97.04
Net Profit -4.39
Net Profit Margin (%) -4.86
Earnings Per Share (EPS) -2.77
EBITDA 0.52
Effective Tax Rate (%) 22.30
Particulars DEC 2022 (Values in Cr)
Revenue 62.93
Operating Expense 62.96
Net Profit 0.43
Net Profit Margin (%) 0.68
Earnings Per Share (EPS) 0.27
EBITDA 6.60
Effective Tax Rate (%) 16.00
Particulars MAR 2023 (Values in Cr)
Revenue 370.20
Operating Expense 370.47
Net Profit 1.27
Net Profit Margin (%) 0.34
Earnings Per Share (EPS) 0.80
EBITDA 25.95
Effective Tax Rate (%) 42.53
Particulars MAR 2022 (Values in Cr)
Revenue 450.86
Operating Expense 423.42
Net Profit 19.66
Net Profit Margin (%) 4.36
Earnings Per Share (EPS) 12.42
EBITDA 49.14
Effective Tax Rate (%) 29.13
Particulars MAR 2021 (Values in Cr)
Revenue 379.98
Operating Expense 345.18
Net Profit 27.97
Net Profit Margin (%) 7.36
Earnings Per Share (EPS) 17.67
EBITDA 58.03
Effective Tax Rate (%) 29.22
Particulars MAR 2020 (Values in Cr)
Revenue 282.35
Operating Expense 277.28
Net Profit 8.25
Net Profit Margin (%) 2.92
Earnings Per Share (EPS) 5.21
EBITDA 24.86
Effective Tax Rate (%) -32.00
Particulars MAR 2019 (Values in Cr)
Revenue 227.58
Operating Expense 233.64
Net Profit -8.03
Net Profit Margin (%) -3.52
Earnings Per Share (EPS) -5.07
EBITDA 10.00
Effective Tax Rate (%) -39.89
Particulars MAR 2023 (Values in Cr)
Book Value / Share 96.00
ROE % 0.84
ROCE % 6.17
Total Debt to Total Equity 0.58
EBITDA Margin 6.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 95.12
ROE % 13.98
ROCE % 17.57
Total Debt to Total Equity 0.56
EBITDA Margin 10.89
Particulars MAR 2021 (Values in Cr)
Book Value / Share 82.63
ROE % 23.83
ROCE % 27.41
Total Debt to Total Equity 0.52
EBITDA Margin 15.27
Particulars MAR 2020 (Values in Cr)
Book Value / Share 65.67
ROE % 8.27
ROCE % 10.51
Total Debt to Total Equity 0.59
EBITDA Margin 7.94
Particulars MAR 2019 (Values in Cr)
Book Value / Share 60.44
ROE % -8.05
ROCE % 1.74
Total Debt to Total Equity 0.67
EBITDA Margin 3.86
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.68
Total Assets 359.62
Total Liabilities 359.62
Total Equity 151.95
Share Outstanding 15828248
Price to Book Ratio 1.02
Return on Assets (%) 0.35
Return on Capital (%) 0.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.95
Total Assets 328.42
Total Liabilities 328.42
Total Equity 150.56
Share Outstanding 15828248
Price to Book Ratio 1.08
Return on Assets (%) 5.98
Return on Capital (%) 8.82
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.59
Total Assets 264.10
Total Liabilities 264.10
Total Equity 130.78
Share Outstanding 15828248
Price to Book Ratio 1.20
Return on Assets (%) 10.59
Return on Capital (%) 14.81
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.62
Total Assets 230.66
Total Liabilities 230.66
Total Equity 103.93
Share Outstanding 15828248
Price to Book Ratio 0.46
Return on Assets (%) 3.57
Return on Capital (%) 5.5
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.43
Total Assets 211.35
Total Liabilities 211.35
Total Equity 95.66
Share Outstanding 15828248
Price to Book Ratio 0.91
Return on Assets (%) -3.79
Return on Capital (%) -5.19
Particulars MAR 2023 (Values in Cr)
Net Income 2.21
Cash from Operations 39.49
Cash from Investing -22.17
Cash from Financing -16.61
Net change in Cash 0.73
Free Cash Flow 67.41
Particulars MAR 2022 (Values in Cr)
Net Income 27.73
Cash from Operations 34.51
Cash from Investing -27.32
Cash from Financing 2.97
Net change in Cash 1.36
Free Cash Flow 62.18
Particulars MAR 2021 (Values in Cr)
Net Income 39.51
Cash from Operations 36.81
Cash from Investing -31.28
Cash from Financing 2.69
Net change in Cash -1.03
Free Cash Flow 68.25
Particulars MAR 2020 (Values in Cr)
Net Income 6.25
Cash from Operations 30.60
Cash from Investing -6.87
Cash from Financing -23.47
Net change in Cash 0.19
Free Cash Flow 37.53
Particulars MAR 2019 (Values in Cr)
Net Income -5.73
Cash from Operations 21.69
Cash from Investing -9.25
Cash from Financing -11.43
Net change in Cash 1.00
Free Cash Flow 31.03
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8857.55 35.96 20.09 20398.94 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
MANGALAM DRUG & CHEM LTD 99.85 0.00 1.13 158.05 85.16 / 132.40
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 98.60
  • 26 Days 99.90
  • 10 Days 98.80
  • 50 Days 103.10
  • 12 Days 99.00
  • 100 Days 102.60
  • 20 Days 99.00
  • 200 Days 105.50
99.75
PIVOT
First Resistance 100.20
Second Resistance 100.60
Third Resistance 101.05
First Support 99.35
Second Support 98.90
Third Support 98.50
RSI 46.96
MACD -0.96
Commodity Channel Index (CCI) -7.82
ADX 12.62
Williams % R -53.85

Over 1 Month

down

0.65

Over 3 Months

down

-12.95

Over 6 Months

down

0.80

Over 1 Year

down

-9.64

Over 3 Years

down

-10.12

Over 5 Years

down

17.95

MANGALAM DRUG & CHEM LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MANGALAM DRUG & CHEM LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
49.42
Promoter Holdings
50.31
FII
0.26
DII
0.0
Promoter Shares(Pledge Percentage)
17.58
Name Category Shares Shares%
Shri Jb Pharma Private Limited Shareholding of Promoter and Promoter Group 2650000.0 16.74
Shree Kishoriju Trading And Investments Private Limited Shareholding of Promoter and Promoter Group 1098515.0 6.94
Shree Rasbihari Trading And Investments Private Limited Shareholding of Promoter and Promoter Group 1011663.0 6.39
Govardhan Murlidhar Dhoot Shareholding of Promoter and Promoter Group 511792.0 3.23
Brijmohan Murlidhar Dhoot Shareholding of Promoter and Promoter Group 486996.0 3.08
Shweta Govardhan Dhoot Shareholding of Promoter and Promoter Group 410000.0 2.59
Ashutosh Taparia Public Shareholding 302000.0 1.91
Smita Aditya Dhoot Shareholding of Promoter and Promoter Group 292500.0 1.85
Radhika Ajay Dhoot Shareholding of Promoter and Promoter Group 292500.0 1.85
Rajkumari Ramniwas Dhoot Shareholding of Promoter and Promoter Group 275948.0 1.74
Jyotiprasad Taparia Public Shareholding 211291.0 1.33
Raj Exports Private Limited Shareholding of Promoter and Promoter Group 191520.0 1.21
Ambika Food Industries Private Limited Public Shareholding 164994.0 1.04
Govardhan Murlidhar Dhoot Shareholding of Promoter and Promoter Group 155330.0 0.98
Dhoot Rekha Govardhan Shareholding of Promoter and Promoter Group 148760.0 0.94
Ajay Ramniwas Dhoot Shareholding of Promoter and Promoter Group 138687.0 0.88
Dhoot Jyoti Brijmohan Shareholding of Promoter and Promoter Group 104550.0 0.66
Aditya Ramniwas Dhoot Shareholding of Promoter and Promoter Group 89225.0 0.56
Brijmohan Murlidhar Dhoot Shareholding of Promoter and Promoter Group 77473.0 0.49
Rajkamal Sukhani Shareholding of Promoter and Promoter Group 28520.0 0.18
Chandrakanta Murlidhar Dhoot Shareholding of Promoter and Promoter Group 67.0 0.0

MANGALAM DRUG & CHEM LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2017-12-21 0.5 Interim 2017-12-22 Equity shares 2005-08-30 0.0 Final 2005-09-01 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MANGALAM DRUG & CHEM LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MANGALAM DRUG & CHEM LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Mangalam Drugs and Organics Ltd?

Answer Field

The share price of Mangalam Drugs and Organics Ltd for NSE is ₹ 100.2 and for BSE is ₹ 99.35.

What is the Market Cap of Mangalam Drugs and Organics Ltd?

Answer Field

The market cap of Mangalam Drugs and Organics Ltd for NSE is ₹ 160.30 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Mangalam Drugs and Organics Ltd?

Answer Field

The 52 Week High and Low of Mangalam Drugs and Organics Ltd for NSE is ₹ 132.45 and ₹ 90.80 and for BSE is ₹ 132.40 and ₹ 85.16.

How to Buy Mangalam Drugs and Organics Ltd share?

Answer Field

You can trade in Mangalam Drugs and Organics Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mangalam Drugs and Organics Ltd?

Answer Field

The 1 year returns on the stock has been -9.64%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader